Across 19 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Mendelson Daniel Newman. Director active across 1 company, notably Champions Oncology, INC.. Aggregated, 25 disclosures have been recorded. Split: 25 buys · 0 sell. Total volume traded: €413k. History available since 22 September 2023. The latest transaction was disclosed on 12 January 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mendelson Daniel Newman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3,812 shares@ US$5.507.0% of flowCommon StockSEC:0001628280-23-032917:0
Canonical exit: 21 Dec 2023 (T+90)
25 of 25 declarations
About Mendelson Daniel Newman
Mendelson Daniel Newman is a Director at Champions Oncology, INC. His 25 filings concern acquisitions, and, across the sampled recent filings from 2023-09-25 to 2024-01-16, purchases total EUR 412797 and sales total EUR 0.